Management of patients with hormone receptor positive, HER2 negative metastatic breast cancer: The expanding role of targeted therapies

Kelcy Henrique, PharmD, RPh

Schedule:        May 26, 2021, 1:30-2:30 pm via WebEx, Dartmouth-Hitchcock Medical Center, Lebanon, NH

Audience:        Accredited for Pharmacists

                         Other interested health care professionals welcome

Credits:           1 Contact Hour knowledge-based

                         0.1CEU will be awarded under the provider


Presenter:       Kelcy Henrique, PharmD, RPh

                         Pharmacy Resident

Registration:   Free to all attendees

Learning Objectives:

After attending this program, participants will be able to:

  1. Describe risk factors, common features and incidence of breast cancer
  2. Determine the most appropriate treatment options for newly diagnosed or relapsed patients
  3. Summarize the key features of commonly used therapies such as dosing, administration, side effects and drug interactions
  4. Review appropriate management strategies and supportive care for supportive care for common toxicities associated with breast cancer therapies

Requirements for Receiving CE Credit:

  • Successful completion of post-presentation questions
  • Participation at live program
  • Complete program evaluation form

This website uses cookies to understand how you use the website and to improve your experience. By continuing to use the website, you accept the University of New England’s use of cookies and similar technologies. To learn more about our use of cookies and how to manage your browser cookie settings, please review our Privacy Notice.